TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T17574 XX ID T17574 XX DT 07.07.2008 (created); ane. DT 17.06.2014 (updated); smt. CO Copyright (C), QIAGEN. XX FA NF-kappaB1-p50 XX SY NF-kappa-B-p105; NF-kappa-B1 p84/NF-kappa-B1 p98; NF-kappaB (p50); p50. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX CL C0020; Rel. XX IN T18455 IkappaB-alpha; Mammalia. IN T19129 NF-kappaB2; mouse, Mus musculus. IN T00595 RelA-p65; mouse, Mus musculus. IN T27517 RelB; Mammalia. XX MX M03557 V$P50_Q6. XX BS R62419. BS R30716. XX DR TRANSPATH: MO000130181. XX RN [1]; RE0053534. RX PUBMED: 15755876. RA Hu J., Colburn N. H. RT Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. RL Mol. Cancer Res. 3:100-109 (2005). RN [2]; RE0053639. RX PUBMED: 15465827. RA Wessells J., Baer M., Young H. A., Claudio E., Brown K., Siebenlist U., Johnson P. F. RT BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. RL J. Biol. Chem. 279:49995-50003 (2004). RN [3]; RE0053748. RX PUBMED: 12871932. RA Demarchi F., Bertoli C., Sandy P., Schneider C. RT Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. RL J. Biol. Chem. 278:39583-39590 (2003). RN [4]; RE0053762. RX PUBMED: 12874295. RA Maier H. J., Marienfeld R., Wirth T., Baumann B. RT Critical role of RelB serine 368 for dimerization and p100 stabilization. RL J. Biol. Chem. 278:39242-39250 (2003). RN [5]; RE0053845. RX PUBMED: 12709443. RA Derudder E., Dejardin E., Pritchard L. L., Green D. R., Korner M., Baud V. RT RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. RL J. Biol. Chem. 278:23278-23284 (2003). RN [6]; RE0054106. RX PUBMED: 9314550. RA Ishikawa H., Carrasco D., Claudio E., Ryseck R. P., Bravo R. RT Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. RL J. Exp. Med. 186:999-1014 (1997). RN [7]; RE0070804. RX PUBMED: 21098220. RA Lou X., Sun S., Chen W., Zhou Y., Huang Y., Liu X., Shan Y., Wang C. RT Negative feedback regulation of NF-kappaB action by CITED2 in the nucleus. RL J. Immunol. 186:539-548 (2011). XX //